Solventum Corporation/$SOLV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Solventum Corporation
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
Ticker
$SOLV
Sector
Primary listing
NYSE
Employees
22,000
Headquarters
Website
SOLV Metrics
BasicAdvanced
$13B
33.04
$2.18
-
-
Price and volume
Market cap
$13B
52-week high
$85.92
52-week low
$60.70
Average daily volume
1.1M
Financial strength
Current ratio
1.224
Quick ratio
0.667
Long term debt to equity
214.403
Total debt to equity
214.403
Interest coverage (TTM)
1.99%
Profitability
EBITDA (TTM)
1,414
Gross margin (TTM)
55.29%
Net profit margin (TTM)
4.53%
Operating margin (TTM)
10.49%
Effective tax rate (TTM)
-18.01%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
3.52%
Return on equity (TTM)
11.67%
Valuation
Price to earnings (TTM)
33.036
Price to revenue (TTM)
1.494
Price to book
3.43
Price to tangible book (TTM)
-3.18
Price to free cash flow (TTM)
85.267
Free cash flow yield (TTM)
1.17%
Free cash flow per share (TTM)
0.846
Growth
Revenue change (TTM)
2.21%
Earnings per share change (TTM)
-64.30%
What the Analysts think about SOLV
Analyst ratings (Buy, Hold, Sell) for Solventum Corporation stock.
Bulls say / Bears say
Management raised full-year 2025 organic sales growth guidance to 2.0%–3.0% and adjusted EPS to $5.80–$5.95, showing confidence in its transformation strategy and ongoing market momentum (PR Newswire)
The company achieved five straight quarters of positive sales volume growth, with Q2 net sales up 3.9% year-over-year to $2.16 billion, underlining steady demand across its range of products (PR Newswire)
Strong segment performance led MedSurg organic revenue to climb 3.9% to $1.22 billion and Health Information Systems organic revenue to rise 3.2%, demonstrating robust growth in key business areas (Investing.com)
GAAP operating margin fell to 9.9% in Q2 from 11.7% a year earlier, showing increasing pressure on margins despite higher revenue (Solventum)
Free cash flow stayed low at $59 million in Q2, even with $214 million in operating income, indicating difficulties in turning profits into cash as the company continues to invest (PR Newswire)
Corporate and unallocated expenses jumped to $182 million in Q2 from $107 million a year ago, dragging down profitability as growth spending increases (Solventum)
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2025.
SOLV Financial Performance
Revenues and expenses
SOLV Earnings Performance
Company profitability
SOLV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Solventum Corporation stock?
Solventum Corporation (SOLV) has a market cap of $13B as of October 08, 2025.
What is the P/E ratio for Solventum Corporation stock?
The price to earnings (P/E) ratio for Solventum Corporation (SOLV) stock is 33.04 as of October 08, 2025.
Does Solventum Corporation stock pay dividends?
No, Solventum Corporation (SOLV) stock does not pay dividends to its shareholders as of October 08, 2025.
When is the next Solventum Corporation dividend payment date?
Solventum Corporation (SOLV) stock does not pay dividends to its shareholders.
What is the beta indicator for Solventum Corporation?
Solventum Corporation (SOLV) does not currently have a Beta indicator.